- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Fasting blood glucose levels may predict prognosis of recanalization procedures like thrombectomy and thrombolysis: Study
A new retrospective study published in the Frontiers in Neurology highlighted the relationship between mean fasting blood glucose (MFBG) levels after the reperfusion of acute large vessel occlusion (ALVO) and patient prognosis. The analysis focused on fasting blood glucose as a significant indicator of patient outcomes following recanalization procedures such as mechanical thrombectomy and bridging thrombolysis.
The study explored the predictive factors influencing functional outcomes at 90 days post-reperfusion. The patients were divided into 2 groups based on their modified Rankin Scale (mRS) scores where one was a good prognosis group (mRS 0–2) and the other a poor prognosis group (mRS 3–6). Out of the total 2,056 participants across 3 major stroke centers in China, 1,370 patients were classified in the good prognosis group, while 686 fell into the poor prognosis category.
This research observed significant differences in age, preoperative mRS scores, diabetes history, and mean fasting blood glucose (MFBG) levels between the two groups (p < 0.001). The patients in the poor prognosis group expressed higher MFBG levels within 72 hours after recanalization. The data analysis demonstrated that these MFBG levels served as independent predictors for stroke outcomes, along with other factors such as age, preoperative functional status, and a history of diabetes.
Through both univariate and multivariate logistic regression analyses, MFBG stood out as a robust predictor of functional recovery which showed a higher predictive value when compared to other variables. The area under the receiver operating characteristic (ROC) curve for MFBG was 0.644 by indicating a noteworthy level of predictive accuracy. This metric surpassed the predictive capacities of age and preoperative mRS that emphasized the critical nature of post-recanalization blood glucose management.
The results underline the importance of closely monitoring fasting blood glucose levels in ALVO patients following vascular reperfusion. Elevated MFBG within the first 72 hours after recanalization may serve as an early warning for clinicians in guiding a more tailored post-procedural care and potentially improving long-term recovery outcomes.
Given the AUC value of 0.644 for MFBG, the clinicians may consider prioritizing glucose level monitoring as part of the early post-procedural evaluation to better stratify risk and implement timely interventions. While age, preoperative health, and diabetes history are important considerations, the monitoring and management of MFBG levels post-reperfusion emerge as pivotal elements in the pursuit of improved patient outcomes following ALVO recanalization.
Reference:
Luo, B., Xiang, Y., Meng, F., Wang, Y., Zhang, Z., Ren, H., & Ma, L. (2024). Impact of fasting blood glucose on prognosis after acute large vessel occlusion reperfusion: results from a multicenter analysis. In Frontiers in Neurology (Vol. 15). Frontiers Media SA. https://doi.org/10.3389/fneur.2024.1422851
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751